12 results
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
investments.
As a research intensive, innovation-focused entity, we have incurred losses and experienced negative operating cash flows since our inception
6-K
CNTB
Connect Biopharma Holdings Ltd
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
22.3 million) in long-term investments.
As a research intensive, innovation-focused entity, we have incurred losses and experienced negative operating
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
includes a subtitle called the Biologics Price Competition and Innovation Act of 2009, or BPCIA, which created an abbreviated approval pathway … for such research; and established a Center for Medicare Innovation at CMS to test innovative payment and service delivery models to lower Medicare and Medicaid
6-K
EX-99.2
ak55p2qt yp
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
424B4
ig8cba1eg8una7ey9
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
0ue 9ev0b9
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
ed1zghnrh6k9z
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
cidhjh lass
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
ft2m7mt a63sw88ntiat
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
tubsx myokoytu4d
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next